Wendy Mayer, VP, Worldwide Innovation, Pfizer
Wendy joined Pfizer in 1997 and has since worn many hats in their commercial organization including in primary care, clinical trials and specialty care market analytics. She is currently responsible for identifying transformative and disruptive platforms and getting them used throughout Pfizer. As she told us, that may mean doing more with less, or it may mean doing less with less!
Charles Saunders, Head of Strategic Diversification, Aetna
Thomas Vanderheyden, VP of Emerging Business Group, UnitedHealth Group
Wendy Mayer, VP of Worldwide Innovation, Pfizer
Sean Chai, Director of Innovation Technology, Kaiser Permanente
In a tribute to end the two days of discussions about scaling, partnering, and commercializing Health 2.0, we heard from two of the biggest “post-insurers”, one of the biggest pharma companies, and America’s leading delivery system.